[go: up one dir, main page]

GB1075270A - Calcium glucohepto-galacturonate - Google Patents

Calcium glucohepto-galacturonate

Info

Publication number
GB1075270A
GB1075270A GB5308964A GB5308964A GB1075270A GB 1075270 A GB1075270 A GB 1075270A GB 5308964 A GB5308964 A GB 5308964A GB 5308964 A GB5308964 A GB 5308964A GB 1075270 A GB1075270 A GB 1075270A
Authority
GB
United Kingdom
Prior art keywords
calcium
galacturonate
aqueous solution
glucoheptonate
glucohepto
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5308964A
Inventor
Marie Francoise Dourdo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Merck Clevenot SA
Original Assignee
Laboratoires Merck Clevenot SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Merck Clevenot SA filed Critical Laboratoires Merck Clevenot SA
Priority to GB5308964A priority Critical patent/GB1075270A/en
Priority to BE672883D priority patent/BE672883A/xx
Priority to FR40105A priority patent/FR5210M/fr
Priority to ES0320261A priority patent/ES320261A1/en
Priority to NL6515828A priority patent/NL6515828A/xx
Publication of GB1075270A publication Critical patent/GB1075270A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals
    • C07H7/033Uronic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

A compound of the formula <FORM:1075270/C2/1> and preparation thereof by mixing equimolecular proportions of calcium glucoheptonate and calcium galacturonate in aqueous solution, heating the mixture to 80 DEG C. then evaporating the bulk of the water and drying the resultant syrup, containing about 70% by weight of the desired product, under a vacuum of 60 mm. of mercury for 1 hr. at a temperature not exceeding 45 DEG C. Calcium glucoheptonate is obtained as an approximately 18% aqueous solution by the action of hydrocyanic acid on D-glucose and treating the intermediate nitrile with slaked lime. Calcium galacturonate is obtained as an approximately 6% aqueous solution by enzymatic hydrolysis of apple pectin using a polygalacturonase to give a double salt of galacturonic acid which is then converted to the calcium salt.ALSO:Pharmaceutical compositions comprise calcium glucohepto-galacturonate of the formula: <FORM:1075270/A5-A6/1> either in solid form, optionally in association with solid pharmaceutical excipients, or in solution and are suitable for oral administration in calcitherapy. The compositions may also include calcium galacturonate and/or calcium glucoheptonate.
GB5308964A 1964-12-31 1964-12-31 Calcium glucohepto-galacturonate Expired GB1075270A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB5308964A GB1075270A (en) 1964-12-31 1964-12-31 Calcium glucohepto-galacturonate
BE672883D BE672883A (en) 1964-12-31 1965-11-26
FR40105A FR5210M (en) 1964-12-31 1965-11-29
ES0320261A ES320261A1 (en) 1964-12-31 1965-12-01 PROCEDURE FOR OBTAINING A NEW CHEMICAL COMPOUND FOR THE TREATMENT OF CALCIUM DEFICIENCIES
NL6515828A NL6515828A (en) 1964-12-31 1965-12-06

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5308964A GB1075270A (en) 1964-12-31 1964-12-31 Calcium glucohepto-galacturonate

Publications (1)

Publication Number Publication Date
GB1075270A true GB1075270A (en) 1967-07-12

Family

ID=10466591

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5308964A Expired GB1075270A (en) 1964-12-31 1964-12-31 Calcium glucohepto-galacturonate

Country Status (5)

Country Link
BE (1) BE672883A (en)
ES (1) ES320261A1 (en)
FR (1) FR5210M (en)
GB (1) GB1075270A (en)
NL (1) NL6515828A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916353B1 (en) * 2007-05-25 2010-09-24 Univ Picardie PHARMACEUTICAL COMPOSITION FOR PRESERVING COLLAGEN

Also Published As

Publication number Publication date
ES320261A1 (en) 1966-09-01
FR5210M (en) 1967-08-07
NL6515828A (en) 1966-07-04
BE672883A (en) 1966-03-16

Similar Documents

Publication Publication Date Title
US6166249A (en) Creatine pyruvates
AU727524B2 (en) Creatine pyruvates and a method of producing them
GB1075270A (en) Calcium glucohepto-galacturonate
GB977214A (en) Chemical compounds
US2446981A (en) Aluminum hydroxide antacid composition
US3907869A (en) Method of producing calcium pangamate
US2611732A (en) Compositions containing mixtures of 4-aminosalicylic acid and its basic calcium salt
US1942660A (en) Process for the preparation of gluconic acid and its lactones
US2686800A (en) Basic aluminum para-amino salicylate and method of making
GB1323478A (en) Process of preparing polyalkylenglycol dibenzoates
GB527864A (en) A process for the production of readily soluble calcium salts
US3109019A (en) Process for preparing a water-soluble sodium salt of acetylsalicylic acid
GB647080A (en) Improvements in or relating to the preparation of readily soluble calcium compounds
Carson Some polygalacturonide n-alkylamides
GB613080A (en) Improvements in the preparation of stable medicinal salts of acetylsalicylic acid
GB788373A (en) Water-soluble derivatives of 5-nitro furfural and production thereof
SU67145A1 (en) The method of obtaining crystalline glucose
GB715976A (en) Improvements in medical preparations for removing toxic heavy metals from the human body
SU143400A1 (en) The method of obtaining pyrrolidine and hexamethyleneimine
SU1710059A1 (en) Preparation for treatment of calves with dehydration
SU145597A1 (en) The method of obtaining soil builders
US2710864A (en) Methoxyphenylheptylamine salt of penicillin
SU115895A1 (en) The method of obtaining adipic diamide and sigma-cyanovalsramid
US2562865A (en) Theobromine alkaline earth metal levulinates
SU466212A1 (en) The method of obtaining hydrochloric acid salts of 1,5-diamino or 1,3,5,7-tetraminoadamanediol-2,6